InsidersTradesSigma
Follow the 노보믹스 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 노보믹스 has published 9 public disclosures. The latest transaction was reported on 28 November 2024 (Purchase). Among the most active insiders: 허용민. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
9 of 9 declarations
Novomix is a company listed on the XKRX market, specializing in the health and pharmaceutical sector. It focuses on the development and commercialization of innovative pharmaceutical products.